Search

Are we making progress on tinnitus?

One of the aspects of tinnitus that drew me into it becoming a major theme of my clinical and research work was how little work had been done when I began to see patients in the mid 1980s. This struck...

Genetics WG4. Improving diagnosis and drug development through the genetic understanding of tinnitus subtypes: a TINNET endeavour

Christopher R Cederroth and Jose Antonio Lopez-Escamez explain how progress is being made to investigate the contribution of genetic factors to tinnitus, including a subtype of ‘extreme’ tinnitus in Ménière’s disease. Genetics WG4 is working towards determining the genetic basis...

The Veterans Hearing Fund

Dawn Bramham introduces us to the newly launched Veterans Hearing Fund (VHF). This organisation aims to improve the lives of military personnel with hearing loss by providing access to technologies, services and bespoke rehabilitation that are not routinely available via...

Multidisciplinary approach to managing individuals with trisomy 21

Michelle Chung and Narad Mathura outline the Down syndrome one-stop clinic; a multidisciplinary clinic introduced at the Children & Young Persons Audiology Centre (CYPAC) at Guys and St Thomas’ NHS Foundation Trust for children and young people with Down syndrome....

Addressing the hearing needs of people with dementia

Dr Dawes provides a comprehensive overview of hearing needs of persons with dementia coupled with recommended guidelines for hearing-related considerations when assessing and intervening with persons with dementia. With ageing populations, we face a global dementia challenge. Rates of both...

The art of hearing: a conversation between silence and colour

The image on the ENT & Audiology News September/October 2025 cover is not merely an artwork – it is a conversation. A conversation in colour. A dialogue between silence and sound, between science and emotion. It is part of a...

2014: Are today’s implantable devices better than conventional solutions for patients with conductive or mixed hearing loss?

Patients with conductive or mixed hearing loss become candidates for amplification when reconstructive surgery is not viable. Three common amplification options are conventional acoustic devices, such as behind-the-ear devices (BTEs), (implantable) bone-conduction devices and active middle ear implants. The goal...

Systemic agents in thyroid cancer

For those patients who have disseminated or unresectable thyroid cancer, Dr Arabella Hunt and Dr Kate Newbold review systemic treatments, their differences, toxicities and outcomes. Thyroid cancer is the most common endocrine malignancy. It is subdivided into differentiated (papillary, follicular...